BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24827408)

  • 1. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
    Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
    Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.
    Ong EW; Xue L; Olmstead MC; Cahill CM
    Br J Pharmacol; 2015 Jan; 172(2):615-29. PubMed ID: 24819092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
    Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
    J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.
    Schramm CL; Honda CN
    Pain; 2010 Dec; 151(3):763-770. PubMed ID: 20970925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy.
    Chabot-Doré AJ; Millecamps M; Stone LS
    J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.
    Schuster DJ; Kitto KF; Overland AC; Messing RO; Stone LS; Fairbanks CA; Wilcox GL
    J Neurosci; 2013 Aug; 33(33):13538-46. PubMed ID: 23946412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.
    Dietis N; Niwa H; Tose R; McDonald J; Ruggieri V; Filaferro M; Vitale G; Micheli L; Ghelardini C; Salvadori S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Br J Pharmacol; 2018 Jul; 175(14):2881-2896. PubMed ID: 29524334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.
    Taylor AM; Roberts KW; Pradhan AA; Akbari HA; Walwyn W; Lutfy K; Carroll FI; Cahill CM; Evans CJ
    Br J Pharmacol; 2015 Jan; 172(2):691-703. PubMed ID: 24923251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
    Fujita W; Gomes I; Devi LA
    Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
    Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
    Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivity of new mu and delta opioid peptides.
    Capasso A
    Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
    Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
    Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
    Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
    Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.